©2013 Baishideng Publishing Group Co.
World J Gastrointest Surg. Aug 27, 2013; 5(8): 239-244
Published online Aug 27, 2013. doi: 10.4240/wjgs.v5.i8.239
Published online Aug 27, 2013. doi: 10.4240/wjgs.v5.i8.239
Table 2 Patient demographics based primary tumor site (n = 3763)
| Duodenum | Jejunum | Ileum | Total | |
| (n = 872) | (n = 324) | (n = 2567) | (n = 3763) | |
| Age | ||||
| ≤ 40 | 4.10% | 6.80% | 5.20% | 5.10% |
| 41-50 | 12.60% | 11.40% | 14.30% | 13.60% |
| 51-60 | 24.00% | 24.70% | 28.20% | 26.90% |
| 61-70 | 28.40% | 27.80% | 25.90% | 26.70% |
| > 70 | 30.80% | 29.30% | 26.30% | 27.60% |
| Gender | ||||
| Female | 46.00% | 43.20% | 50.80% | 49.00% |
| Male | 54.00% | 56.80% | 49.20% | 51.00% |
| Race | ||||
| White | 67.90% | 82.40% | 88.40% | 83.20% |
| Black | 23.30% | 15.70% | 9.30% | 13.10% |
| Asian/other | 8.80% | 1.90% | 2.30% | 3.70% |
| Geographic region | ||||
| East | 38.90% | 32.70% | 34.20% | 35.10% |
| Northern plains | 14.90% | 14.20% | 15.80% | 15.50% |
| Pacific coast | 39.70% | 44.40% | 42.90% | 42.30% |
| Southwest | 6.50% | 8.60% | 7.10% | 7.10% |
| Year of diagnosis | ||||
| 1988-1992 | 4.40% | 9.60% | 8.10% | 7.30% |
| 1993-1997 | 7.10% | 10.50% | 12.50% | 11.10% |
| 1998-2003 | 30.30% | 31.80% | 29.80% | 30.10% |
| 2004-2009 | 58.30% | 48.10% | 49.60% | 51.50% |
| Number of primaries | ||||
| 1 | 88.40% | 90.70% | 87.60% | 88.00% |
| 2+ | 11.60% | 9.30% | 12.40% | 12.00% |
| Extent of surgery | ||||
| Local excision | 62.20% | 4.30% | 3.20% | 17.00% |
| Resection | 35.30% | 88.60% | 88.00% | 75.80% |
| Debulking | 2.50% | 7.10% | 8.80% | 7.20% |
| Number of lymph nodes examined | ||||
| 0 | 81% | 35% | 20% | 36% |
| 1-6 | 13% | 34% | 29% | 26% |
| 7-12 | 4% | 19% | 23% | 18% |
| 13+ | 3% | 11% | 28% | 20% |
| Tumor size (cm) | ||||
| 0.1-1.0 | 42% | 20% | 20% | 25% |
| 1.1-2.0 | 15% | 41% | 35% | 31% |
| 2.1+ | 9% | 24% | 31% | 25% |
| Unknown | 34% | 14% | 14% | 18% |
| T-stage | ||||
| T1 | 60% | 8% | 12% | 23% |
| T2 | 10% | 12% | 14% | 13% |
| T3 | 3% | 42% | 39% | 31% |
| T4 | 5% | 32% | 29% | 24% |
| TNOS | 21% | 6% | 6% | 10% |
| N-stage | ||||
| N0 | 12% | 13% | 16% | 15% |
| N1 | 7% | 52% | 64% | 49% |
| Unknown | 81% | 35% | 20% | 36% |
| M-stage | ||||
| M0 | 97% | 75% | 74% | 79% |
| M1 | 3% | 25% | 26% | 21% |
| TNM-stage | ||||
| I | 6% | 1% | 4% | 4% |
| IIA | 2% | 1% | 3% | 2% |
| IIB | 1% | 5% | 4% | 3% |
| IIIA | 1% | 2% | 2% | 1% |
| IIIB | 5% | 37% | 45% | 35% |
| IV | 3% | 25% | 26% | 21% |
| Unknown | 83% | 30% | 16% | 33% |
- Citation: Hari DM, Goff SL, Reich HJ, Leung AM, Sim MS, Lee JH, Wolin E, Amersi F. Small bowel carcinoid: Location isn’t everything! World J Gastrointest Surg 2013; 5(8): 239-244
- URL: https://www.wjgnet.com/1948-9366/full/v5/i8/239.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v5.i8.239